INPI

government agency

Last mentioned: Mar 24, 2026

Timeline

  1. Brazil Patent Grant

    Recce Pharmaceuticals officially receives patent grant from the Brazilian National Institute of Industrial Property (INPI).

  2. Clinical Expansion

    Recce expands Phase II clinical trials for RECCE® 327 in topical and intravenous applications.

  3. US Patent Milestone

    Recce secures key composition of matter patents in the United States, strengthening its North American position.

Stories mentioning INPI 1

ip-patent Neutral

Recce Pharmaceuticals Secures Key Brazilian Patent for Anti-Infective Platform

Recce Pharmaceuticals has been granted a critical patent in Brazil for its synthetic anti-infective platform, marking a significant expansion into South America's largest healthcare market. The patent protects the composition and manufacturing of its lead candidates, RECCE® 327 and RECCE® 529, as the company targets the global antimicrobial resistance crisis.

2 sources